Loading...
Gene editing and gene-based therapeutics for cardiomyopathies
With an increasing understanding of genetic defects leading to cardiomyopathy, focus is shifting to methods for correcting these underlying genetic defects. One approach involves treating mutant RNA through antisense oligonucleotides, and the first drug has now received regulatory approval to treat...
Saved in:
| Published in: | Heart Fail Clin |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5849064/ https://ncbi.nlm.nih.gov/pubmed/29525646 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hfc.2017.12.006 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|